Delivery Order SPE2DB20D2001-SPE2DB23FM27G
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,804.29 firm fixed-price delivery order covers the procurement of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of August 6, 2021. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,506.72 firm-fixed-price delivery order is for the supply of PREMARIN 0.625 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.44 firm fixed-price delivery order is for the supply of PREMARIN 0.3 MG TABLET 100S, with a period of performance through July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,481.33, is a Firm Fixed Price Delivery Order for the supply of PREMARIN 0.625 MG TABLET 100S. The contract has an ultimate completion date of April 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,396.41, is a Firm Fixed Price Delivery Order for the supply of PREMARIN 0.625 MG TABLET 100S. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,184.20 firm fixed-price delivery order is for PREMARIN 0.625 MG TABLET 100S and has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,784.91 firm fixed-price delivery order is for the supply of Premarin 0.625 mg tablets, a hormone medication, with a completion date of December 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREMARIN 0.3 MG TABLET 100S. The $2,071.60 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,575.96 firm fixed-price delivery order contract is for the supply of PREMARIN 0.3 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,575.59 firm fixed-price delivery order is for the supply of PREMARIN 0.625 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM27GDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,358.29 firm fixed-price delivery order is for the supply of PREMARIN 0.625 MG TABLET 1000S, with an ultimate completion date of October 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 10/26/22 |